L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts movement, vision...
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
Scientists are turning to retinas as a potential screening target for early signs of Alzheimer's, an incurable neurodegenerative disease that...
Primary Progressive Aphasia is a type of young onset dementia that is characterised by language impairment. Measuring disease progression and...
Stereotypical depictions of speech in cannabis users often suggest slow, laboured output, yet objective evidence supporting this assumption is extremely...
Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...
The paper describes the outcomes from a clinical trial for Friedreich ataxia (the most common hereditary ataxia impacting walking, talking,...
Critically ill patients, like those in intensive care units, are a highly complex and varied group. Many critically ill patients...
Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development and Mobile...
In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an outcome measure...